Therapy-related Changes of CD20+ and CD45RO+ Lymphocyte Subsets in Chronic Myeloid Leukemia (CML): An Immunohistochemical and Morphometric Study on Sequential ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2000-08-01

AUTHORS

Juergen Thiele, Hans Michael Kvasnicka, Annette Schmitt-Graeff, Gabriela Cvetanovska, Nicole Blum, Hans Eckart Schaefer

ABSTRACT

Little information exists about the amount of CD45RO+-T- and CD20+-B-lymphocytes in the bone marrow of patients with Philadelphia chromosome-positive chronic myelogenous leukemia (Ph1+-CML) at presentation or regarding corresponding changes during therapy. On the other hand, quantification of this cell compartment seems to be imperative for two reasons: first, the presumed association of immunocompetent lymphocyte subsets in the expansion of the leukemic cell clone; and second, a speculated relationship with the complex generation of myelofibrosis. Therefore, an immunohistological and morphometric study was performed on 219 representative trephine biopsies of the bone marrow derived from 70 patients with repeated examinations during the course of Ph1+-CML. For the identification of the different lymphocyte populations, the monoclonal antibodies UCHL-1 (CD45R0) and L26 (CD20) were applied on formaldehyde-fixed and decalcified specimens. In comparison to a control group and calculated per hematopoietic cells, the CML bone marrow showed about a 50% decrease in the total amount of lymphocytes. Determination of CD45RO+ and CD20+ subsets revealed a significant enhancement during treatment. Because of the different intervals (range, 10 to 25 mo) between first and last biopsy in the various therapeutic groups, results had to be modified by considering dynamic features. This calculation included changes of the lymphocyte subpopulations related to time. Contrasting the CD45RO+ lymphocytes, a relevant increase in the CD20+ subset could be observed after interferon-α treatment or corresponding combination regimens. No significant correlations were found between fiber density at onset (first biopsy) or development of fibrosis and lymphocyte proliferations in the course of CML. Our results are in keeping with the finding that a proper immune response consistent with an increased lymphocyte growth seems to be associated with a regression of the clonally-transformed cell population. Opposed to a repeatedly discussed pathomechanism, we failed to demonstrate any quantitative relationships between the extent of lymphocyte proliferations and occurrence or progression of myelofibrosis. More... »

PAGES

888-896

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/modpathol.3880159

DOI

http://dx.doi.org/10.1038/modpathol.3880159

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1039943917

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10955456


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, CD20", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biopsy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Marrow", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Busulfan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cohort Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hydroxyurea", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoenzyme Techniques", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interferon-alpha", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukocyte Common Antigens", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocyte Subsets", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vincristine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institute of Pathology, Universities of Cologne, Germany", 
          "id": "http://www.grid.ac/institutes/grid.6190.e", 
          "name": [
            "Institute of Pathology, Universities of Cologne, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thiele", 
        "givenName": "Juergen", 
        "id": "sg:person.01160664600.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160664600.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Pathology, Universities of Cologne, Germany", 
          "id": "http://www.grid.ac/institutes/grid.6190.e", 
          "name": [
            "Institute of Pathology, Universities of Cologne, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kvasnicka", 
        "givenName": "Hans Michael", 
        "id": "sg:person.012401210064.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012401210064.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Freiburg, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schmitt-Graeff", 
        "givenName": "Annette", 
        "id": "sg:person.0657700770.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657700770.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Pathology, Universities of Cologne, Germany", 
          "id": "http://www.grid.ac/institutes/grid.6190.e", 
          "name": [
            "Institute of Pathology, Universities of Cologne, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cvetanovska", 
        "givenName": "Gabriela", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Pathology, Universities of Cologne, Germany", 
          "id": "http://www.grid.ac/institutes/grid.6190.e", 
          "name": [
            "Institute of Pathology, Universities of Cologne, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Blum", 
        "givenName": "Nicole", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Freiburg, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schaefer", 
        "givenName": "Hans Eckart", 
        "id": "sg:person.01116304300.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116304300.49"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00199918", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010474499", 
          "https://doi.org/10.1007/bf00199918"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1701008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053556316", 
          "https://doi.org/10.1038/sj.bmt.1701008"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01606516", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033936926", 
          "https://doi.org/10.1007/bf01606516"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00641309", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014377247", 
          "https://doi.org/10.1007/bf00641309"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2000-08-01", 
    "datePublishedReg": "2000-08-01", 
    "description": "Little information exists about the amount of CD45RO+-T- and CD20+-B-lymphocytes in the bone marrow of patients with Philadelphia chromosome-positive chronic myelogenous leukemia (Ph1+-CML) at presentation or regarding corresponding changes during therapy. On the other hand, quantification of this cell compartment seems to be imperative for two reasons: first, the presumed association of immunocompetent lymphocyte subsets in the expansion of the leukemic cell clone; and second, a speculated relationship with the complex generation of myelofibrosis. Therefore, an immunohistological and morphometric study was performed on 219 representative trephine biopsies of the bone marrow derived from 70 patients with repeated examinations during the course of Ph1+-CML. For the identification of the different lymphocyte populations, the monoclonal antibodies UCHL-1 (CD45R0) and L26 (CD20) were applied on formaldehyde-fixed and decalcified specimens. In comparison to a control group and calculated per hematopoietic cells, the CML bone marrow showed about a 50% decrease in the total amount of lymphocytes. Determination of CD45RO+ and CD20+ subsets revealed a significant enhancement during treatment. Because of the different intervals (range, 10 to 25 mo) between first and last biopsy in the various therapeutic groups, results had to be modified by considering dynamic features. This calculation included changes of the lymphocyte subpopulations related to time. Contrasting the CD45RO+ lymphocytes, a relevant increase in the CD20+ subset could be observed after interferon-\u03b1 treatment or corresponding combination regimens. No significant correlations were found between fiber density at onset (first biopsy) or development of fibrosis and lymphocyte proliferations in the course of CML. Our results are in keeping with the finding that a proper immune response consistent with an increased lymphocyte growth seems to be associated with a regression of the clonally-transformed cell population. Opposed to a repeatedly discussed pathomechanism, we failed to demonstrate any quantitative relationships between the extent of lymphocyte proliferations and occurrence or progression of myelofibrosis.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/modpathol.3880159", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1098208", 
        "issn": [
          "0893-3952", 
          "1530-0285"
        ], 
        "name": "Modern Pathology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "13"
      }
    ], 
    "keywords": [
      "chronic myeloid leukemia", 
      "bone marrow", 
      "lymphocyte subsets", 
      "trephine biopsy", 
      "lymphocyte proliferation", 
      "course of CML", 
      "monoclonal antibodies UCHL-1", 
      "Philadelphia chromosome-positive chronic myelogenous leukemia", 
      "sequential trephine biopsies", 
      "chromosome-positive chronic myelogenous leukemia", 
      "therapy-related changes", 
      "interferon-\u03b1 treatment", 
      "different lymphocyte populations", 
      "progression of myelofibrosis", 
      "CML bone marrow", 
      "development of fibrosis", 
      "chronic myelogenous leukemia", 
      "morphometric study", 
      "leukemic cell clone", 
      "proper immune response", 
      "last biopsy", 
      "lymphocyte subpopulations", 
      "combination regimens", 
      "UCHL-1", 
      "lymphocyte populations", 
      "myeloid leukemia", 
      "immune response", 
      "myelogenous leukemia", 
      "B lymphocytes", 
      "CD20", 
      "control group", 
      "therapeutic groups", 
      "lymphocyte growth", 
      "biopsy", 
      "marrow", 
      "fiber density", 
      "cell clones", 
      "relevant increase", 
      "cell populations", 
      "patients", 
      "significant correlation", 
      "myelofibrosis", 
      "lymphocytes", 
      "hematopoietic cells", 
      "leukemia", 
      "cell compartment", 
      "treatment", 
      "little information", 
      "proliferation", 
      "different intervals", 
      "subset", 
      "regimens", 
      "group", 
      "fibrosis", 
      "therapy", 
      "pathomechanism", 
      "population", 
      "Immunohistochemical", 
      "complex generation", 
      "progression", 
      "course", 
      "corresponding changes", 
      "subpopulations", 
      "L26", 
      "presentation", 
      "onset", 
      "examination", 
      "association", 
      "study", 
      "changes", 
      "cells", 
      "total amount", 
      "regression", 
      "Ph1", 
      "findings", 
      "compartments", 
      "response", 
      "interval", 
      "decrease", 
      "relationship", 
      "clones", 
      "specimens", 
      "occurrence", 
      "increase", 
      "correlation", 
      "results", 
      "extent", 
      "identification", 
      "significant enhancement", 
      "development", 
      "amount", 
      "reasons", 
      "quantification", 
      "hand", 
      "time", 
      "comparison", 
      "quantitative relationship", 
      "features", 
      "growth", 
      "information", 
      "enhancement", 
      "expansion", 
      "determination", 
      "generation", 
      "density", 
      "dynamic features", 
      "calculations"
    ], 
    "name": "Therapy-related Changes of CD20+ and CD45RO+ Lymphocyte Subsets in Chronic Myeloid Leukemia (CML): An Immunohistochemical and Morphometric Study on Sequential Trephine Biopsies of the Bone Marrow", 
    "pagination": "888-896", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1039943917"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/modpathol.3880159"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10955456"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/modpathol.3880159", 
      "https://app.dimensions.ai/details/publication/pub.1039943917"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:23", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_344.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/modpathol.3880159"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/modpathol.3880159'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/modpathol.3880159'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/modpathol.3880159'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/modpathol.3880159'


 

This table displays all metadata directly associated to this object as RDF triples.

296 TRIPLES      21 PREDICATES      155 URIs      143 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/modpathol.3880159 schema:about N11e2d65925904350ac4edf9ad92cfdb3
2 N271d0d1e4c884492bf4e812c1f0650e5
3 N2df07d665c984995a8ec03ed2bd330da
4 N4abad0300b50476980a99646f3cb7593
5 N586e47e4650640e5b116060e51d7d09c
6 N5a6e2b02068b441ba18c6844f870eb15
7 N66e894b6efec44418843e3e33ad61638
8 N764ded92233d4d93b13939131cc73b9e
9 N780d5f09cd0e4b21a29f684356a78584
10 N7dbb2545282146799497f747eb2e5b25
11 N821df6f83bca494aab4eabf8520a4d91
12 N8962dcfb405942d1ab84b75878376bf4
13 N95234045aba04bc2baf231d1dee944e8
14 N9f292fd9004b46dfac469a642b233b36
15 Ne4d80c52d3814f09b21e9b13eb142081
16 Ne6a724d4eca448b0a1d50123a0c7674b
17 Nf07a8996d41b46ed9a6be9660a8262c3
18 Nf15ab4e29730436c8d7141e51ca3da57
19 Nf5c9bf6b2d624f5b8d8062af79106330
20 anzsrc-for:11
21 anzsrc-for:1107
22 schema:author N349ebfd3f58741e5b2cd92f01f946f44
23 schema:citation sg:pub.10.1007/bf00199918
24 sg:pub.10.1007/bf00641309
25 sg:pub.10.1007/bf01606516
26 sg:pub.10.1038/sj.bmt.1701008
27 schema:datePublished 2000-08-01
28 schema:datePublishedReg 2000-08-01
29 schema:description Little information exists about the amount of CD45RO+-T- and CD20+-B-lymphocytes in the bone marrow of patients with Philadelphia chromosome-positive chronic myelogenous leukemia (Ph1+-CML) at presentation or regarding corresponding changes during therapy. On the other hand, quantification of this cell compartment seems to be imperative for two reasons: first, the presumed association of immunocompetent lymphocyte subsets in the expansion of the leukemic cell clone; and second, a speculated relationship with the complex generation of myelofibrosis. Therefore, an immunohistological and morphometric study was performed on 219 representative trephine biopsies of the bone marrow derived from 70 patients with repeated examinations during the course of Ph1+-CML. For the identification of the different lymphocyte populations, the monoclonal antibodies UCHL-1 (CD45R0) and L26 (CD20) were applied on formaldehyde-fixed and decalcified specimens. In comparison to a control group and calculated per hematopoietic cells, the CML bone marrow showed about a 50% decrease in the total amount of lymphocytes. Determination of CD45RO+ and CD20+ subsets revealed a significant enhancement during treatment. Because of the different intervals (range, 10 to 25 mo) between first and last biopsy in the various therapeutic groups, results had to be modified by considering dynamic features. This calculation included changes of the lymphocyte subpopulations related to time. Contrasting the CD45RO+ lymphocytes, a relevant increase in the CD20+ subset could be observed after interferon-α treatment or corresponding combination regimens. No significant correlations were found between fiber density at onset (first biopsy) or development of fibrosis and lymphocyte proliferations in the course of CML. Our results are in keeping with the finding that a proper immune response consistent with an increased lymphocyte growth seems to be associated with a regression of the clonally-transformed cell population. Opposed to a repeatedly discussed pathomechanism, we failed to demonstrate any quantitative relationships between the extent of lymphocyte proliferations and occurrence or progression of myelofibrosis.
30 schema:genre article
31 schema:isAccessibleForFree true
32 schema:isPartOf N8567cc11ff8b48ecad9717f9b85750e0
33 Nb8d2abd56c1f4fff80a1c507103e41e2
34 sg:journal.1098208
35 schema:keywords B lymphocytes
36 CD20
37 CML bone marrow
38 Immunohistochemical
39 L26
40 Ph1
41 Philadelphia chromosome-positive chronic myelogenous leukemia
42 UCHL-1
43 amount
44 association
45 biopsy
46 bone marrow
47 calculations
48 cell clones
49 cell compartment
50 cell populations
51 cells
52 changes
53 chromosome-positive chronic myelogenous leukemia
54 chronic myelogenous leukemia
55 chronic myeloid leukemia
56 clones
57 combination regimens
58 comparison
59 compartments
60 complex generation
61 control group
62 correlation
63 corresponding changes
64 course
65 course of CML
66 decrease
67 density
68 determination
69 development
70 development of fibrosis
71 different intervals
72 different lymphocyte populations
73 dynamic features
74 enhancement
75 examination
76 expansion
77 extent
78 features
79 fiber density
80 fibrosis
81 findings
82 generation
83 group
84 growth
85 hand
86 hematopoietic cells
87 identification
88 immune response
89 increase
90 information
91 interferon-α treatment
92 interval
93 last biopsy
94 leukemia
95 leukemic cell clone
96 little information
97 lymphocyte growth
98 lymphocyte populations
99 lymphocyte proliferation
100 lymphocyte subpopulations
101 lymphocyte subsets
102 lymphocytes
103 marrow
104 monoclonal antibodies UCHL-1
105 morphometric study
106 myelofibrosis
107 myelogenous leukemia
108 myeloid leukemia
109 occurrence
110 onset
111 pathomechanism
112 patients
113 population
114 presentation
115 progression
116 progression of myelofibrosis
117 proliferation
118 proper immune response
119 quantification
120 quantitative relationship
121 reasons
122 regimens
123 regression
124 relationship
125 relevant increase
126 response
127 results
128 sequential trephine biopsies
129 significant correlation
130 significant enhancement
131 specimens
132 study
133 subpopulations
134 subset
135 therapeutic groups
136 therapy
137 therapy-related changes
138 time
139 total amount
140 treatment
141 trephine biopsy
142 schema:name Therapy-related Changes of CD20+ and CD45RO+ Lymphocyte Subsets in Chronic Myeloid Leukemia (CML): An Immunohistochemical and Morphometric Study on Sequential Trephine Biopsies of the Bone Marrow
143 schema:pagination 888-896
144 schema:productId N09868760f83f47dcb6ca7da304dd442d
145 N91e2290715544f1fbfdc0092c28553aa
146 N97e800bf25f042fa8f4359e05a60ce47
147 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039943917
148 https://doi.org/10.1038/modpathol.3880159
149 schema:sdDatePublished 2022-12-01T06:23
150 schema:sdLicense https://scigraph.springernature.com/explorer/license/
151 schema:sdPublisher N9d9b351b79734a00a9d74d4388298f57
152 schema:url https://doi.org/10.1038/modpathol.3880159
153 sgo:license sg:explorer/license/
154 sgo:sdDataset articles
155 rdf:type schema:ScholarlyArticle
156 N09868760f83f47dcb6ca7da304dd442d schema:name doi
157 schema:value 10.1038/modpathol.3880159
158 rdf:type schema:PropertyValue
159 N11e2d65925904350ac4edf9ad92cfdb3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Drug Therapy, Combination
161 rdf:type schema:DefinedTerm
162 N134c9ee286a4411b8b34661d4fbf8597 rdf:first sg:person.012401210064.05
163 rdf:rest Nbf0ab22c4d0c4f99b73ead010aecf9d0
164 N271d0d1e4c884492bf4e812c1f0650e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Busulfan
166 rdf:type schema:DefinedTerm
167 N27f55f6831d049329dc8b088c892b134 schema:affiliation grid-institutes:grid.6190.e
168 schema:familyName Cvetanovska
169 schema:givenName Gabriela
170 rdf:type schema:Person
171 N2df07d665c984995a8ec03ed2bd330da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Adult
173 rdf:type schema:DefinedTerm
174 N349ebfd3f58741e5b2cd92f01f946f44 rdf:first sg:person.01160664600.08
175 rdf:rest N134c9ee286a4411b8b34661d4fbf8597
176 N4abad0300b50476980a99646f3cb7593 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Leukemia, Myelogenous, Chronic, BCR-ABL Positive
178 rdf:type schema:DefinedTerm
179 N586e47e4650640e5b116060e51d7d09c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Leukocyte Common Antigens
181 rdf:type schema:DefinedTerm
182 N5a6e2b02068b441ba18c6844f870eb15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Antineoplastic Agents
184 rdf:type schema:DefinedTerm
185 N66e894b6efec44418843e3e33ad61638 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Hydroxyurea
187 rdf:type schema:DefinedTerm
188 N764ded92233d4d93b13939131cc73b9e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Middle Aged
190 rdf:type schema:DefinedTerm
191 N780d5f09cd0e4b21a29f684356a78584 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Male
193 rdf:type schema:DefinedTerm
194 N78b7cdc1d4194053b206d7b2f5e1dbda rdf:first N7d22873ac8754979a70313f4d474734a
195 rdf:rest N9c25b48d68ae463e8fbf24eaa3c1e661
196 N7d22873ac8754979a70313f4d474734a schema:affiliation grid-institutes:grid.6190.e
197 schema:familyName Blum
198 schema:givenName Nicole
199 rdf:type schema:Person
200 N7dbb2545282146799497f747eb2e5b25 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Cohort Studies
202 rdf:type schema:DefinedTerm
203 N821df6f83bca494aab4eabf8520a4d91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Female
205 rdf:type schema:DefinedTerm
206 N8567cc11ff8b48ecad9717f9b85750e0 schema:issueNumber 8
207 rdf:type schema:PublicationIssue
208 N8962dcfb405942d1ab84b75878376bf4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
209 schema:name Immunoenzyme Techniques
210 rdf:type schema:DefinedTerm
211 N91e2290715544f1fbfdc0092c28553aa schema:name pubmed_id
212 schema:value 10955456
213 rdf:type schema:PropertyValue
214 N95234045aba04bc2baf231d1dee944e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
215 schema:name Vincristine
216 rdf:type schema:DefinedTerm
217 N97e800bf25f042fa8f4359e05a60ce47 schema:name dimensions_id
218 schema:value pub.1039943917
219 rdf:type schema:PropertyValue
220 N9c25b48d68ae463e8fbf24eaa3c1e661 rdf:first sg:person.01116304300.49
221 rdf:rest rdf:nil
222 N9d9b351b79734a00a9d74d4388298f57 schema:name Springer Nature - SN SciGraph project
223 rdf:type schema:Organization
224 N9f292fd9004b46dfac469a642b233b36 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
225 schema:name Lymphocyte Subsets
226 rdf:type schema:DefinedTerm
227 Nb8d2abd56c1f4fff80a1c507103e41e2 schema:volumeNumber 13
228 rdf:type schema:PublicationVolume
229 Nbf0ab22c4d0c4f99b73ead010aecf9d0 rdf:first sg:person.0657700770.48
230 rdf:rest Nc47293fda06d48668845a538f1d00823
231 Nc47293fda06d48668845a538f1d00823 rdf:first N27f55f6831d049329dc8b088c892b134
232 rdf:rest N78b7cdc1d4194053b206d7b2f5e1dbda
233 Ne4d80c52d3814f09b21e9b13eb142081 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
234 schema:name Antigens, CD20
235 rdf:type schema:DefinedTerm
236 Ne6a724d4eca448b0a1d50123a0c7674b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
237 schema:name Biopsy
238 rdf:type schema:DefinedTerm
239 Nf07a8996d41b46ed9a6be9660a8262c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
240 schema:name Humans
241 rdf:type schema:DefinedTerm
242 Nf15ab4e29730436c8d7141e51ca3da57 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
243 schema:name Interferon-alpha
244 rdf:type schema:DefinedTerm
245 Nf5c9bf6b2d624f5b8d8062af79106330 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
246 schema:name Bone Marrow
247 rdf:type schema:DefinedTerm
248 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
249 schema:name Medical and Health Sciences
250 rdf:type schema:DefinedTerm
251 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
252 schema:name Immunology
253 rdf:type schema:DefinedTerm
254 sg:journal.1098208 schema:issn 0893-3952
255 1530-0285
256 schema:name Modern Pathology
257 schema:publisher Springer Nature
258 rdf:type schema:Periodical
259 sg:person.01116304300.49 schema:affiliation grid-institutes:None
260 schema:familyName Schaefer
261 schema:givenName Hans Eckart
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116304300.49
263 rdf:type schema:Person
264 sg:person.01160664600.08 schema:affiliation grid-institutes:grid.6190.e
265 schema:familyName Thiele
266 schema:givenName Juergen
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160664600.08
268 rdf:type schema:Person
269 sg:person.012401210064.05 schema:affiliation grid-institutes:grid.6190.e
270 schema:familyName Kvasnicka
271 schema:givenName Hans Michael
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012401210064.05
273 rdf:type schema:Person
274 sg:person.0657700770.48 schema:affiliation grid-institutes:None
275 schema:familyName Schmitt-Graeff
276 schema:givenName Annette
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657700770.48
278 rdf:type schema:Person
279 sg:pub.10.1007/bf00199918 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010474499
280 https://doi.org/10.1007/bf00199918
281 rdf:type schema:CreativeWork
282 sg:pub.10.1007/bf00641309 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014377247
283 https://doi.org/10.1007/bf00641309
284 rdf:type schema:CreativeWork
285 sg:pub.10.1007/bf01606516 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033936926
286 https://doi.org/10.1007/bf01606516
287 rdf:type schema:CreativeWork
288 sg:pub.10.1038/sj.bmt.1701008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053556316
289 https://doi.org/10.1038/sj.bmt.1701008
290 rdf:type schema:CreativeWork
291 grid-institutes:None schema:alternateName Freiburg, Germany
292 schema:name Freiburg, Germany
293 rdf:type schema:Organization
294 grid-institutes:grid.6190.e schema:alternateName Institute of Pathology, Universities of Cologne, Germany
295 schema:name Institute of Pathology, Universities of Cologne, Germany
296 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...